Vanguard disaggregates holdings; reports 0% in Incyte (INCY)
Rhea-AI Filing Summary
Incyte Corp Schedule 13G/A amendment reports that The Vanguard Group holds 0% of Incyte common stock, with 0 shares beneficially owned as of the filing. The amendment explains an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries to report ownership separately in reliance on SEC Release No. 34-39538.
The filing is signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings, reporting zero beneficial ownership for the parent entity.
The amendment documents an internal reorganization at The Vanguard Group dated January 12, 2026, after which certain subsidiaries report holdings separately under SEC Release No. 34-39538. The filing lists 0 shares and 0% beneficial ownership for the parent entity.
Impact depends on subsidiary-level filings; subsequent disclosures will show where holdings migrated and any voting/dispositive control retained by affiliate entities.
FAQ
What does The Vanguard Group's Schedule 13G/A for INCY report?
Why did Vanguard report zero ownership in the INCY amendment?
Does the INCY filing say Vanguard subsidiaries still hold shares?
Who signed the INCY Schedule 13G/A amendment for Vanguard?
Does this amendment change Vanguard's voting or dispositive power in INCY?